Software - Application
Compare Stocks
4 / 10Stock Comparison
NICE vs LPSN vs FIVN vs SPOK
Revenue, margins, valuation, and 5-year total return — side by side.
Software - Application
Software - Infrastructure
Medical - Healthcare Information Services
NICE vs LPSN vs FIVN vs SPOK — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Software - Application | Software - Application | Software - Infrastructure | Medical - Healthcare Information Services |
| Market Cap | $5.78B | $32M | $1.70B | $225M |
| Revenue (TTM) | $2.95B | $244M | $1.17B | $103M |
| Net Income (TTM) | $612M | $-67M | $57M | $11M |
| Gross Margin | 66.4% | 62.2% | 55.1% | 91.4% |
| Operating Margin | 21.9% | -9.6% | 4.7% | 13.2% |
| Forward P/E | 8.7x | — | 7.0x | 16.4x |
| Total Debt | $164M | $392M | $847M | $7M |
| Cash & Equiv. | $379M | $95M | $232M | $25M |
NICE vs LPSN vs FIVN vs SPOK — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| NICE Ltd. (NICE) | 100 | 51.4 | -48.6% |
| LivePerson, Inc. (LPSN) | 100 | 0.5 | -99.5% |
| Five9, Inc. (FIVN) | 100 | 21.3 | -78.7% |
| Spok Holdings, Inc. (SPOK) | 100 | 105.5 | +5.5% |
Price return only. Dividends and distributions are not included.
Quick Verdict: NICE vs LPSN vs FIVN vs SPOK
Each card shows where this stock fits in a portfolio — not just who wins on paper.
NICE is the #2 pick in this set and the best alternative if sleep-well-at-night is your priority.
- Lower volatility, beta 0.72, Low D/E 4.2%, current ratio 1.55x
- 20.8% margin vs LPSN's -27.6%
- 11.8% ROA vs LPSN's -12.4%, ROIC 13.2% vs -6.6%
LPSN lags the leaders in this set but could rank higher in a more targeted comparison.
FIVN carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.
- Rev growth 10.3%, EPS growth 370.6%, 3Y rev CAGR 13.8%
- 125.4% 10Y total return vs NICE's 50.7%
- 10.3% revenue growth vs LPSN's -22.0%
- Lower P/E (7.0x vs 16.4x)
SPOK is the clearest fit if your priority is income & stability and defensive.
- Dividend streak 5 yrs, beta 0.42, yield 11.9%
- Beta 0.42, yield 11.9%, current ratio 1.18x
- Beta 0.42 vs LPSN's 2.05
- 11.9% yield; 5-year raise streak; the other 3 pay no meaningful dividend
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 10.3% revenue growth vs LPSN's -22.0% | |
| Value | Lower P/E (7.0x vs 16.4x) | |
| Quality / Margins | 20.8% margin vs LPSN's -27.6% | |
| Stability / Safety | Beta 0.42 vs LPSN's 2.05 | |
| Dividends | 11.9% yield; 5-year raise streak; the other 3 pay no meaningful dividend | |
| Momentum (1Y) | -11.9% vs LPSN's -77.1% | |
| Efficiency (ROA) | 11.8% ROA vs LPSN's -12.4%, ROIC 13.2% vs -6.6% |
NICE vs LPSN vs FIVN vs SPOK — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
NICE vs LPSN vs FIVN vs SPOK — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
NICE leads in 1 of 6 categories
SPOK leads 1 • LPSN leads 0 • FIVN leads 0 • 4 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
Evenly matched — NICE and FIVN and SPOK each lead in 2 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
NICE is the larger business by revenue, generating $2.9B annually — 28.5x SPOK's $103M. NICE is the more profitable business, keeping 20.8% of every revenue dollar as net income compared to LPSN's -27.6%. On growth, FIVN holds the edge at +9.2% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $2.9B | $244M | $1.2B | $103M |
| EBITDAEarnings before interest/tax | $845M | -$562,000 | $140M | $17M |
| Net IncomeAfter-tax profit | $612M | -$67M | $57M | $11M |
| Free Cash FlowCash after capex | $665M | -$43M | $206M | $26M |
| Gross MarginGross profit ÷ Revenue | +66.4% | +62.2% | +55.1% | +91.4% |
| Operating MarginEBIT ÷ Revenue | +21.9% | -9.6% | +4.7% | +13.2% |
| Net MarginNet income ÷ Revenue | +20.8% | -27.6% | +4.9% | +10.3% |
| FCF MarginFCF ÷ Revenue | +22.6% | -17.4% | +17.6% | +24.7% |
| Rev. Growth (YoY)Latest quarter vs prior year | +9.0% | -19.0% | +9.2% | -100.0% |
| EPS Growth (YoY)Latest quarter vs prior year | +56.5% | +79.4% | +20.0% | -64.0% |
Valuation Metrics
Evenly matched — NICE and LPSN each lead in 2 of 6 comparable metrics.
Valuation Metrics
At 9.9x trailing earnings, NICE trades at a 80% valuation discount to FIVN's 48.3x P/E. On an enterprise value basis, NICE's 6.6x EV/EBITDA is more attractive than FIVN's 16.8x.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $5.8B | $32M | $1.7B | $225M |
| Enterprise ValueMkt cap + debt − cash | $5.6B | $329M | $2.3B | $206M |
| Trailing P/EPrice ÷ TTM EPS | 9.89x | -0.22x | 48.26x | 14.44x |
| Forward P/EPrice ÷ next-FY EPS est. | 8.74x | — | 6.96x | 16.41x |
| PEG RatioP/E ÷ EPS growth rate | 0.37x | — | — | — |
| EV / EBITDAEnterprise value multiple | 6.59x | — | 16.84x | 8.91x |
| Price / SalesMarket cap ÷ Revenue | 1.96x | 0.13x | 1.48x | 1.61x |
| Price / BookPrice ÷ Book value/share | 1.56x | — | 2.46x | 1.56x |
| Price / FCFMarket cap ÷ FCF | 8.22x | — | 8.45x | 8.91x |
Profitability & Efficiency
NICE leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
NICE delivers a 16.4% return on equity — every $100 of shareholder capital generates $16 in annual profit, vs $7 for SPOK. NICE carries lower financial leverage with a 0.04x debt-to-equity ratio, signaling a more conservative balance sheet compared to FIVN's 1.08x. On the Piotroski fundamental quality scale (0–9), FIVN scores 8/9 vs LPSN's 5/9, reflecting strong financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | +16.4% | — | +7.4% | +7.3% |
| ROA (TTM)Return on assets | +11.8% | -12.4% | +3.2% | +5.2% |
| ROICReturn on invested capital | +13.2% | -6.6% | +1.7% | +11.3% |
| ROCEReturn on capital employed | +16.1% | -5.8% | +2.2% | +12.1% |
| Piotroski ScoreFundamental quality 0–9 | 7 | 5 | 8 | 6 |
| Debt / EquityFinancial leverage | 0.04x | — | 1.08x | 0.05x |
| Net DebtTotal debt minus cash | -$216M | $297M | $615M | -$18M |
| Cash & Equiv.Liquid assets | $379M | $95M | $232M | $25M |
| Total DebtShort + long-term debt | $164M | $392M | $847M | $7M |
| Interest CoverageEBIT ÷ Interest expense | — | 0.20x | 7.94x | — |
Total Returns (Dividends Reinvested)
Evenly matched — FIVN and SPOK each lead in 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in SPOK five years ago would be worth $16,194 today (with dividends reinvested), compared to $35 for LPSN. Over the past 12 months, FIVN leads with a -11.9% total return vs LPSN's -77.1%. The 3-year compound annual growth rate (CAGR) favors SPOK at 4.3% vs LPSN's -65.4% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | -14.6% | -31.1% | +18.0% | -14.3% |
| 1-Year ReturnPast 12 months | -40.4% | -77.1% | -11.9% | -26.7% |
| 3-Year ReturnCumulative with dividends | -49.3% | -95.8% | -61.4% | +13.4% |
| 5-Year ReturnCumulative with dividends | -59.1% | -99.7% | -87.0% | +61.9% |
| 10-Year ReturnCumulative with dividends | +50.7% | -97.0% | +125.4% | +13.3% |
| CAGR (3Y)Annualised 3-year return | -20.2% | -65.4% | -27.2% | +4.3% |
Risk & Volatility
Evenly matched — FIVN and SPOK each lead in 1 of 2 comparable metrics.
Risk & Volatility
SPOK is the less volatile stock with a 0.42 beta — it tends to amplify market swings less than LPSN's 2.05 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. FIVN currently trades 73.1% from its 52-week high vs LPSN's 12.4% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.72x | 2.05x | 1.79x | 0.42x |
| 52-Week HighHighest price in past year | $180.61 | $21.60 | $30.38 | $19.31 |
| 52-Week LowLowest price in past year | $94.89 | $2.37 | $13.29 | $9.96 |
| % of 52W HighCurrent price vs 52-week peak | +53.0% | +12.4% | +73.1% | +56.1% |
| RSI (14)Momentum oscillator 0–100 | 40.9 | 40.3 | 68.1 | 36.7 |
| Avg Volume (50D)Average daily shares traded | 631K | 148K | 2.8M | 185K |
Analyst Outlook
SPOK leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
Analyst consensus: NICE as "Buy", FIVN as "Buy", SPOK as "Hold". Consensus price targets imply 57.8% upside for NICE (target: $151) vs 27.9% for FIVN (target: $28). SPOK is the only dividend payer here at 11.95% yield — a key consideration for income-focused portfolios.
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | — | Buy | Hold |
| Price TargetConsensus 12-month target | $150.88 | — | $28.40 | $15.00 |
| # AnalystsCovering analysts | 23 | — | 41 | 1 |
| Dividend YieldAnnual dividend ÷ price | — | — | — | +11.9% |
| Dividend StreakConsecutive years of raises | 0 | — | — | 5 |
| Dividend / ShareAnnual DPS | — | — | — | $1.29 |
| Buyback YieldShare repurchases ÷ mkt cap | +8.5% | 0.0% | +2.9% | +1.3% |
NICE leads in 1 of 6 categories (Profitability & Efficiency). SPOK leads in 1 (Analyst Outlook). 4 tied.
NICE vs LPSN vs FIVN vs SPOK: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is NICE or LPSN or FIVN or SPOK a better buy right now?
For growth investors, Five9, Inc.
(FIVN) is the stronger pick with 10. 3% revenue growth year-over-year, versus -22. 0% for LivePerson, Inc. (LPSN). NICE Ltd. (NICE) offers the better valuation at 9. 9x trailing P/E (8. 7x forward), making it the more compelling value choice. Analysts rate NICE Ltd. (NICE) a "Buy" — based on 23 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — NICE or LPSN or FIVN or SPOK?
On trailing P/E, NICE Ltd.
(NICE) is the cheapest at 9. 9x versus Five9, Inc. at 48. 3x. On forward P/E, Five9, Inc. is actually cheaper at 7. 0x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — NICE or LPSN or FIVN or SPOK?
Over the past 5 years, Spok Holdings, Inc.
(SPOK) delivered a total return of +61. 9%, compared to -99. 7% for LivePerson, Inc. (LPSN). Over 10 years, the gap is even starker: FIVN returned +125. 4% versus LPSN's -97. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — NICE or LPSN or FIVN or SPOK?
By beta (market sensitivity over 5 years), Spok Holdings, Inc.
(SPOK) is the lower-risk stock at 0. 42β versus LivePerson, Inc. 's 2. 05β — meaning LPSN is approximately 388% more volatile than SPOK relative to the S&P 500. On balance sheet safety, NICE Ltd. (NICE) carries a lower debt/equity ratio of 4% versus 108% for Five9, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — NICE or LPSN or FIVN or SPOK?
By revenue growth (latest reported year), Five9, Inc.
(FIVN) is pulling ahead at 10. 3% versus -22. 0% for LivePerson, Inc. (LPSN). On earnings-per-share growth, the picture is similar: Five9, Inc. grew EPS 370. 6% year-over-year, compared to 2. 7% for Spok Holdings, Inc.. Over a 3-year CAGR, FIVN leads at 13. 8% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — NICE or LPSN or FIVN or SPOK?
NICE Ltd.
(NICE) is the more profitable company, earning 20. 8% net margin versus -27. 6% for LivePerson, Inc. — meaning it keeps 20. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: NICE leads at 21. 9% versus -9. 6% for LPSN. At the gross margin level — before operating expenses — SPOK leads at 78. 8%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is NICE or LPSN or FIVN or SPOK more undervalued right now?
On forward earnings alone, Five9, Inc.
(FIVN) trades at 7. 0x forward P/E versus 16. 4x for Spok Holdings, Inc. — 9. 5x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for NICE: 57. 8% to $150. 88.
08Which pays a better dividend — NICE or LPSN or FIVN or SPOK?
In this comparison, SPOK (11.
9% yield) pays a dividend. NICE, LPSN, FIVN do not pay a meaningful dividend and should not be held primarily for income.
09Is NICE or LPSN or FIVN or SPOK better for a retirement portfolio?
For long-horizon retirement investors, Spok Holdings, Inc.
(SPOK) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 42), 11. 9% yield). LivePerson, Inc. (LPSN) carries a higher beta of 2. 05 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (SPOK: +13. 3%, LPSN: -97. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between NICE and LPSN and FIVN and SPOK?
These companies operate in different sectors (NICE (Technology) and LPSN (Technology) and FIVN (Technology) and SPOK (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: NICE is a small-cap deep-value stock; LPSN is a small-cap quality compounder stock; FIVN is a small-cap quality compounder stock; SPOK is a small-cap deep-value stock. SPOK pays a dividend while NICE, LPSN, FIVN do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.